Efficacy of superimposing neuromuscular electrical stimulation onto core stability exercise in patients with nonspecific low back pain: A study protocol for a randomized controlled trial

Y Yongzhong Li Q Qian Fang Z Zhe Meng (Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, National Key Laboratory of Innovative Immunotherapy, School of Chemistry and Chemical Engineering) X Xuan Li (Department of Chemistry) H Haixin Song J Jianhua Li

Abstract

Introduction Non-specific low back pain (NSLBP) is a prevalent condition affecting individuals worldwide, leading to significant disability and healthcare costs. Traditional treatment methods have shown limited efficacy, prompting the exploration of innovative approaches. Core stability exercise (CSE) has emerged as a promising rehabilitation strategy, yet optimal activation of local muscle systems remains to be fully understood. This trial aims to assess the efficacy of superimposing neuromuscular electrical stimulation (NMES) onto CSE for improving muscle activation, function, and proprioception in NSLBP patients. Methods and analysis A total of 52 participants aged 18–60 years with NSLBP will be randomly allocated into two groups: (1) experimental group receiving NMES superimposed on CSE and (2) control group undergoing the same CSE with sham NMES. Interventions will occur three times per week for six weeks. The primary outcome measures will encompass surface electromyography (sEMG) to assess muscle activity and muscle activation timing. Secondary outcomes will include the evaluation of pain intensity using the Visual Analog Scale (VAS) and disability measured by the Oswestry Disability Index (ODI), as well as proprioception assessed through joint repositioning error (JRE) and muscle thickness evaluated via real-time ultrasound image (RUSI). Data will be collected at baseline, after six weeks, and at a six-month follow-up. A mixed ANOVA will be employed to compare differences among groups and to analyze trends over time as well as interaction effects between treatment and time. Trial registration Trial registration number: Chinese Clinical Trial Registry (ChiCTR2400092409)

Article Details

Journal PLoS ONE
Volume / Issue Vol. 20, Issue 5
Published May 07, 2025
Pages e0322398
ISSN 1932-6203
Publisher Public Library of Science

Journal Info

PLoS ONE

Public Library of Science

ISSN: 1932-6203 Open Access Health Sciences

Authors (6)

Y

Yongzhong Li

Q

Qian Fang

Z

Zhe Meng

Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, National Key Laboratory of Innovative Immunotherapy, School of Chemistry and Chemical Engineering

X

Xuan Li

Department of Chemistry

H

Haixin Song

J

Jianhua Li